We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00366665
First Posted: August 21, 2006
Last Update Posted: August 21, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Medical University of South Carolina
  Purpose
To compare the efficiency of the Infiniti vision system and the Series 20000 Legacy System phacoemulsification units during routine cataract extraction.

Condition Intervention
Cataract Extraction Device: Legacy 20000 Device: Infinit system

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Comparison of the Infiniti Vision and the Series 20000 Legacy Systems

Resource links provided by NLM:


Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Ultrasound time
  • Amount of fluid used
  • Post operative visual acuity.

Estimated Enrollment: 30
Study Start Date: March 2005
Estimated Study Completion Date: May 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cataract
  • Eligible for cataract extraction with primary implantation of a posterior chamber IOL
  • 2 to 3+ cataract density

Exclusion Criteria:

  • Preoperative ocular pathology that can affect visual acuity
  • Corneal irregularities such as keratoconus, corneal dystrophy, corneal opacities.
  • Previous intraocular or corneal surgery.
  • Other ocular surgery at the time of the cataract extraction.
  • Surgical Exclusion Criteria:
  • Significant intraoperative intraocular bleeding
  • Detached Descemet’s membrane
  • Implantation of the intraocular lens in the anterior chamber or sulcus
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00366665


Sponsors and Collaborators
Medical University of South Carolina
Investigators
Principal Investigator: Kerry D. Solomon, MD Medical University of South Carolina
  More Information

ClinicalTrials.gov Identifier: NCT00366665     History of Changes
Other Study ID Numbers: MRC-05-002
First Submitted: August 17, 2006
First Posted: August 21, 2006
Last Update Posted: August 21, 2006
Last Verified: May 2005

Additional relevant MeSH terms:
Cataract
Lens Diseases
Eye Diseases